CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 18 enrolled
Drug / intervention
Duloxetinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00471315
NCT00471315Phase 3Completed
CompareCT.gov

Pilot Study of the Efficacy and Tolerability of Duloxetine in Patients With Suspected Functional Pancreatic/Biliary Pain (Sphincter of Oddi Dysfunction).

Medical University of South Carolina·interventional·Posted May 9, 2007·Updated Feb 6, 2014

In Brief

A Phase 3 clinical trial evaluating Duloxetine for Sphincter of Oddi Dysfunction. Completed, enrolled 18 participants across 1 site.

Detailed Summary

Open-label single center study of duloxetine in patients with SOD who have failed to respond to the standard treatments. This protocol is designed to explore the tolerability and efficacy of Duloxetine in the management of patients with known or suspected Sphincter of Oddi dysfunction (SOD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSphincter of Oddi Dysfunction
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 9, 2007
Enrollment StartJul 1, 2006
Primary CompletionMar 1, 2012
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 19.1 years ago

Interventions

Duloxetinedrug

A preliminary, open-label single center study of duloxetine in patients with SOD